A column on ISPACOS activities was published on the column interview page of the AMED iD3 Catalist Unit HP of the University of Tokyo. English website iD3 Catalyst Unit | Patient empowerment as a new trend in drug development: beyond the goal of ISPACOS

ISPACOS article was published in “ONCOLO”, a cancer information Website. Cancer information site “ONCOLO” HP https://oncolo.jp/

We are pleased to announce that an article about ISPACOS appeared in “PHARMACY NEWSBREAK” published by Jiho Corporation. 【Media Name】PHARMACY NEWSBREAK 【Date of Publication】 Wednesday, March 11, 2020 【Contents】 Grassroots multidisciplinary team of medical professionals and patients urges pharmacists to “pay special attention” to Olaparib medication guidance. Article URL: http://pnb.jiho.jp/tabid/68/pdid/25249/Default.aspx Nikkan Yakuyo: https://nk.jiho.jp/article/149625 Due to […]

ISPACOS visited the Japan Pharmaceutical Association on August 5, 2019, and the Japanese Society of Hospital Pharmacists on November 6, 2019, and submitted a written request for “Considerations for Olaparib during Medication Instruction (Request).” On Feburary 21, 2020, both pharmaceutical associations issued attention notice. We are pleased to report that the voices of patients have […]

ISPACOS visited the Japanese Society of Hospital Pharmacists on November 6, 2019 and submitted a written request for “Consideration when giving medication instructions regarding Olaparib (Request)”, hoping to ensure patient-friendly medication instructions by improving coordination between hospitals and pharmacies.